The Latest Breaking News from Vinay Prasad

Trump administration gives no details about reason for departure of Vinay Prasad, but he had critics and had taken unusual actions

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program

Amid Trump cuts and state-level backlash, experts worry that progress in messenger RNA vaccines could stall

The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.’s (NASDAQ:MRNA) supplemental Biologics License Application (sBLA) for Spikevax, the company’s COVID-19 vaccine, in children six months through 11 years of age who are at increased risk for COVID-19 disease.

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines

Frustration and anger mount as Trump administration contemplates new trials and restrictions for Covid vaccines

On May 27, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention will no longer include the COVID-19 vaccine on the list of immunizations it recommends for healthy children and pregnant women.

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

Critics say shift will negatively affect people who are not high risk but want to be vaccinated against the disease